Chester County News and Community Website
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced that the U.S. Patent and Trademark Office has issued a new patent covering its lead investigational therapy, istaroxime, for intravenous treatment …
Windtree Therapeutics Secures U.S. Patent for Istaroxime Heart Failure Treatment Read More WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced its plan to release interim data from the SEISMiC SCAI Stage C Phase 2 study (SEISMiC C Study) by July …
Windtree Therapeutics Targets July for Interim Data from Key Cardiogenic Shock Study Read More WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. patent application number …
Windtree Therapeutics Secures Patent for Istaroxime IV Formulation in Acute Heart Failure Read More